Brain dopamine response in human opioid addiction

British Journal of Psychiatry

Volumn 193, Issue 1, 2008, Pages 65-72

  Daglish, Mark R C ^a,b   Williams, Tim M ^a,b   Wilson, Sue J ^a   Taylor, Lindsay G ^a,b   Eap, Chin B ^c   Augsburger, Marc ^d   Giroud, Christian ^d   Brooks, David J ^b   Myles, Judy S ^e   Grasby, Paul ^b   Lingford Hughes, Anne R ^a,b   Nutt, David J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c Psychiatric Hospital CERY   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e Bristol Specialist Drug Service   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; DOPAMINE; HYDROMORPHONE; METHADONE; OPIATE; PLACEBO; RACLOPRIDE C 11;

ADULT; ARTICLE; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; HEROIN DEPENDENCE; HUMAN; OPIATE ADDICTION; POSITRON EMISSION TOMOGRAPHY; SACCADIC EYE MOVEMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; BRAIN; DOPAMINE; DOUBLE-BLIND METHOD; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 46749125031     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.107.041228     Document Type: Article

References (34)

1. 11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry 1997; 154: 1209-13.
2. Brody A, Olmstead R, London E, Farahi J, Meyer J, Grossman P, Lee G, Huang J, Hahn E, Mandelkern M. Smoking-induced ventral striatum dopamine release. Am J Psychiatry 2004; 161: 1211-8.
3. Boileau I, Assaad J, Pihl R, Benkelfat C, Leyton M, Diksic M, Tremblay R, Dagher A. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 2003; 49: 226-31.
4. Volkow N, Wang G, Fowler J, Logan J, Gatley S, Wong C, Hitzemann R, Pappas N. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther 1999; 291: 409-15.
5. Gerrits M, Ramsey N, Wolterink G, Van Ree J. Lack of evidence for an involvement of nucleus accumbens dopamine D1 receptors in the initiation of heroin self-administration in the rat. Psychopharmacology 1994; 114: 486-94.
6. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274-8.
7. Volkow N, Wang G, Fowler J, Logan J, Gatley S, Hitzemann R, Chen A, Dewey S, Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997; 386: 830-3.
8. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-10). World Health Organization, 1992.
9. Gunn R, Lammertsma A, Hume S, Cunningham V. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 1997; 6: 279-87.
10. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang D, Huang Y, Simpson N, Ngo K, Van Heertum R, Laruelle M. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 2001; 21: 1034-57.
11. Jenkinson C, Layte R, Wright L, Coulter A. The UK SF-36: An Analysis and Interpretation Manual. A Guide to Health Status Measurement with Particular Reference to the Short Form 36 Health Survey. University of Oxford, Department of Public Health and Primary Care, Health Services Research Unit, 1996.
12. Eysenck H, Eysenck S. Manual of the Eysenck Personality Scales (EPS Adult). Hodder and Stoughton, 1971.
13. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607-14.
14. Anton R, Moak D, Latham P. The Obsessive Compulsive Drinking Scale. A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 1996; 53: 225-31.
15. Martin W, Sloan J, Sapira J, Jasinski D. Physiologic, subjective and behavioural effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 1971; 12: 245-58.
16. Jasinski D. Assessment of the abuse potential of morphine-like drugs (methods used in man). In Drug Addiction I: Morphine, Sedative/Hypnotic and Alcohol Dependence (ed W Martin): 197-258. Springer-Verlag, 1977.
17. Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists' Press, 1983.
18. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
19. Law F, Bailey J, Allen D, Melichar J, Myles J, Mitcheson M, Lewis J, Nutt D. The feasibility of abrupt methadone-buprenorphine transfer in British opiate addicts in an outpatient setting. Addict Biol 1997; 2: 191-200.
20. Melichar J, Myles J, Eap C, Nutt D. Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test. Addict Biol 2003; 8: 59-66.
21. Crettol S, Deglon J, Besson J, Croquette-Krokkar M, Gothuey I, Hammig R, Monnat M, Huttemann H, Baumann P, Eap CB. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment. Clin Pharmacol Ther 2005; 78: 593-604.
22. Dienes-Nagy A, Rivier L, Giroud C, Augsburger M, Mangin P. Method for quantification of morphine and its 3- and 6-glucuronides, codeine, codeine glucuronide and 6-monoacetylmorphine in human blood by liquid chromatography-electrospray mass spectrometry for routine analysis in forensic toxicology. J Chromatogr A 1999; 854: 109-18.
23. Ridenour T, Maldonado-Molina M, Compton W, Spitznagel E, Cottler L. Factors associated with the transition from abuse to dependence among substance abusers. Implications for a measure of addictive liability. Drug Alcohol Depend 2005; 80: 1-14.
24. Martinez D, Gil R, Slifstein M, Hwang D, Huang Y, Perez A, Kegeles L, Talbot P, Evans S, Krystal J, Laruelle M, Abi-Dargham A. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 2005; 58: 779-86.
25. 2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacol 1997; 16: 174-82.
26. 2 receptor binding in man. Synapse 2002; 45: 25-30.
27. 3 receptor binding in healthy subjects. Pain 2004; 109: 86-93.
28. Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry 2006; 63: 808-16.
29. 11C] raclopride PET study. Synapse 2007; 61: 637-45.
30. Mitrovic I, Napier TC. Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum. Eur J Neurosci 2002; 15: 257-68.
31. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 2000; 20: 423-51.
32. Robinson T, Berridge K. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993; 18: 247-91.
33. 11C]raclopride study in healthy men. Neuropsychopharmacol 2002; 27: 1027-35.
34. Breiter H, Gollub R, Weisskoff R, Kennedy D, Makris N, Berke J, Goodman J, Kantor H, Gastfriend D, Riorden J, Mathew R, Rosen B, Hyman S. Acute effects of cocaine on human brain activity and emotion. Neuron 1997; 19: 591-611.